What oral penicillin‑ase‑resistant penicillin can be used as an equivalent to oxacillin for treating methicillin‑susceptible Staphylococcus aureus infections?

Oral Equivalent to Oxacillin

Dicloxacillin or cephalexin are the recommended oral equivalents to intravenous oxacillin for treating methicillin-susceptible Staphylococcus aureus (MSSA) infections 1.

Primary Recommendation

The IDSA guidelines explicitly recommend dicloxacillin or cephalexin as first-line oral agents for MSSA infections, specifically noting their use for conditions like impetigo and ecthyma where S. aureus isolates are typically methicillin-susceptible 1. These penicillinase-resistant penicillins (dicloxacillin) and first-generation cephalosporins (cephalexin) serve as the direct oral counterparts to parenteral oxacillin.

Supporting Evidence

Multiple sources confirm that penicillinase-resistant penicillins remain the antibiotics of choice for MSSA infections 2, 3. The class includes:

• Dicloxacillin (oral penicillinase-resistant penicillin)
• Flucloxacillin (where available, primarily outside the US)
• Cephalexin (oral first-generation cephalosporin alternative)

Research demonstrates that dicloxacillin maintains consistent activity against MSSA strains, though it shows heterogeneous resistance patterns against MRSA that limit its use in those infections 4.

Clinical Algorithm for Selection

When transitioning from IV oxacillin to oral therapy:

1. Confirm MSSA susceptibility - Oxacillin should only be used for penicillinase-producing staphylococci 5
2. Choose dicloxacillin as first-line oral agent for most MSSA infections
3. Use cephalexin as alternative if dicloxacillin unavailable or not tolerated
4. Avoid in penicillin allergy - Use clindamycin, doxycycline, or TMP-SMX instead 1

Important Caveats

• Do not use for MRSA: When MRSA is suspected or confirmed, switch to doxycycline, clindamycin, or TMP-SMX 1
• Cephalosporins contraindicated in immediate hypersensitivity: Patients with urticaria, angioedema, bronchospasm, or anaphylaxis to penicillins should not receive cephalexin 2
• Severity matters: Serious MSSA infections may require continued parenteral therapy rather than oral step-down 3
• Duration typically 7 days for uncomplicated skin and soft tissue infections 1

The evidence strongly supports dicloxacillin as the most direct oral equivalent, with cephalexin serving as an appropriate alternative within the same therapeutic class for MSSA coverage.